Boomerang Medical is a women-led bioelectronic medicine company on a mission to disrupt the treatment of autoimmune diseases. The company is developing a bioelectric neuromodulation technology, which has been granted Breakthrough Device Designation by the FDA for the treatment of Crohn's disease and ulcerative colitis. The technology is being evaluated in a multi-center, single-arm clinical trial at leading IBD centers in the US.
Headquartered in the heart of Silicon Valley on the campus of El Camino Hospital, Boomerang is a Company-In-Residence at the prestigious Fogarty Innovation incubator – the only healthcare-focused incubator/accelerator of its kind in the US – giving us access to the brightest minds and expertise in the medical technology industry.
The rate of auto-immune diseases in the U.S. population has been increasing for several decades. Recent research estimates that 51 million people in the U.S. (16% of the U.S. population) may be affected by a full-clinical or pre-clinical auto-immune disease. While the etiologies of most auto-immune diseases remain unknown, it has been well described that once triggered, the body is unable to balance its immune response. The body begins to mistake its own healthy tissue as foreign, and mounts an inappropriate attack against itself. In a normal immune state, the nervous system and immune system act in harmony to defend the body from pathogens and then return the body to stability, otherwise referred to as homeostasis. When there is an inability to appropriately regulate an immune response, homeostasis is lost and an auto-immune reaction triggered. Over time, this hyperimmune state can lead to chronic inflammation and subsequent tissue damage. The result of this process is manifested in a variety of disease states, such as inflammatory bowel disease (Crohn's disease and ulcerative colitis) and rheumatoid arthritis. Bioelectronic medicine focuses on electric signaling within the nervous system to assist the body in restoring homeostasis, with the goal of obviating chronic inflammatory pathways.
Meet the Team
Board of Directors + Advisors
Boomerang Medical is proud to be a portfolio company of Arboretum Ventures and Hatteras Venture Partners, as well as a Company In Residence at Fogarty Innovation
President & CEO
Chief Executive Officer
Tom Shehab, MD
Chief Financial Officer
Hatteras Venture Partners
Director of Innovation Acceleration